Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Apellis Pharmaceuticals, Inc.
  6. Funds
  7. Fonds Positionnés
    APLS   US03753U1060

APELLIS PHARMACEUTICALS, INC.

(APLS)
  Report
Real-time Estimate Cboe BZX  -  03:08:20 2023-01-27 pm EST
52.34 USD   -0.84%
01/25Insider Sell: Apellis Pharmaceuticals
MT
01/09Transcript : Apellis Pharmaceuticals, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:00 AM
CI
01/09Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
ETFs positioned on APELLIS PHARMACEUTICALS, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco DWA Healthcare Momentum ETF - USD3.36%0.42%United_States
Virtus LifeSci Biotech Products ETF - USD2.54%3.07%United_States
SPDR S&P Biotech ETF - USD1.08%4.36%United_States
Global X S&P Biotech ETF - AUD1.08%-0.44%-United_States
IShares Nasdaq US Biotechnology (D) - USD0.74%1.40%United_States
IShares Nasdaq US Biotechnology - USD0.74%1.48%United_States
Invesco Nasdaq Biotechnology ETF - USD0.73%0.87%-United_States
IShares Biotechnology ETF - USD0.61%2.32%-NC
Xtrackers MSCI Genomic Healthcare Innovatio...0.6%1.83%-NC
Invesco Raymond James SB-1 Equity ETF - USD0.57%4.02%United_States
IShares Russell 2000 Growth ETF - USD0.55%1.90%United_States
Vanguard Russell 2000 Growth ETF - USD0.55%1.93%United_States
IShares Morningstar Small-Cap Growth ETF - USD0.39%3.79%-NC
BMO MSCI Genomic Innovation Index ETF - CAD0.38%0.00%-NC
Vanguard Small-Cap Growth ETF - USD0.35%1.94%United_States
Vanguard Russell 2000 ETF - USD0.28%3.64%United_States
IShares Russell 2000 ETF - USD0.28%1.99%United_States
Xtrackers Russell 2000 1C - USD0.28%3.21%United_States
BNY Mellon US Small Cap Core Equity ETF - USD0.26%3.92%-NC
First Trust Mid Cap Growth AlphaDEX Fund - USD0.22%1.80%United_States
Schwab U.S. Small-Cap ETF - USD0.2%3.99%United_States
IShares Morningstar Small-Cap ETF - USD0.2%1.91%-NC
Schwab U.S. Mid-Cap ETF - USD0.18%4.11%United_States
Vanguard Small Cap ETF - USD0.15%3.95%United_States
SoFi Next 500 - USD0.13%4.17%United_States
First Trust Mid Cap Core AlphaDEX Fund - USD0.11%4.31%United_States
Vanguard Extended Market ETF - USD0.11%2.25%United_States
Fidelity MSCI Health Care Index ETF - USD0.1%0.67%United_States
Vanguard MSCI International Small Companies...0.09%-0.85%-World
Goldman Sachs ActiveBeta U.S. Small Cap Equ...0.09%1.61%United_States
First Trust Multi Cap Growth AlphaDEX Fund - USD0.07%1.46%United_States
Vanguard Health Care ETF - USD0.06%0.66%United_States
Fidelity NASDAQ Composite Index ETF - USD0.05%6.07%-United_States
Vanguard Russell 3000 ETF - USD0.02%4.26%United_States
IShares Core S&P Total U.S. Stock Market ETF - USD0.02%4.17%United_States
IShares Dow Jones U.S. ETF - USD0.02%2.22%United_States
IShares Russell 3000 ETF - USD0.02%4.16%United_States
Schwab 1000 Index� ETF - USD0.02%4.20%United_States
Vanguard Total Stock Market ETF - USD0.02%4.15%United_States
Vanguard FTSE Global All Cap ex Canada Inde...0.01%2.33%World
IShares Core MSCI All Country World ex Cana...0%0.00%-World
IShares Core MSCI All Country World ex Cana...0%2.25%World



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart APELLIS PHARMACEUTICALS, INC.
Duration : Period :
Apellis Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 52,78 $
Average target price 74,69 $
Spread / Average Target 41,5%
Chart APELLIS PHARMACEUTICALS, INC.
Duration : Period :
Apellis Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
APELLIS PHARMACEUTICALS, INC.2.07%5 831
CSL LIMITED2.91%101 251
SAMSUNG BIOLOGICS CO.,LTD.-3.17%45 824
BIOGEN INC.5.42%42 037
WUXI BIOLOGICS (CAYMAN) INC.19.30%38 535
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.19.07%24 669